Immunotherapy for Parkinson’s disease

Immunotherapy for Parkinson’s disease

With the increasing prevalence of Parkinson’s disease (PD), there is an immediate need to interdict disease signs and symptoms. In recent years this need was met through therapeutic approaches focused on regenerative stem cell replacement and alpha-synuclein clearance. However, neither have shown lo...

Full description

Bibliographic Details
Main Authors: Aaron D. Schwab, Mackenzie J. Thurston, Jatin Machhi, Katherine E. Olson, Krista L. Namminga, Howard E. Gendelman, R. Lee Mosley
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Neurobiology of Disease
Subjects:
Immune transformation
Regulatory T cells
Tregs
Effector T cells
Teffs
Granulocyte-macrophage colony stimulating factor
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996120300358

Internet

http://www.sciencedirect.com/science/article/pii/S0969996120300358

Similar Items